Analysts Split On Abbott Lab’s Purchase Of St. Jude
April 29, 2016 at 14:14 PM EDT
Abbott Laboratories ( ABT ) and St. Jude ( STJ ) are both trading lower on Friday afternoon, a day after Abbott said it would buy St. Jude for $25 billion in cash and stock. The $85 per share stock price for St. Jude is a 37% premium to its Thursday closing price; Abbott expects to close the deal before the end of the year, and for the deal to be accretive in the first full year afterward. Read More »